China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
Nvidia Options Price in $280 Billion Earnings Swing 
Tesla Raises Cybertruck Prices by $5,000 in US 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Trump Buys SpaceX Shares After Record IPO 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Add as a preferred source on Google
RICHLAND, Wash., April 26, 2018 -- IsoRay, Inc. (the “Company”) (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced that it will host a teleconference to discuss third quarter fiscal 2018 financial results on Thursday, May 3, 2018, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the third quarter of fiscal 2018 ended March 31, 2018, immediately after the close of the market on May 3, 2018.
Interested parties are asked to dial-in approximately 10 minutes before the call begins at the following numbers:
U.S. Participants: (877) 270-2148
International Participants: + 1-412-902-6510
Participant Passcode: 10119919
The earnings release and a replay of the call will be available through the Investor Relations section of the Company’s website: https://isoray.com/about/investors/presentations/. A replay of the call will be available for one week beginning at approximately 10:00 p.m. Eastern Time on May 3, 2018. The playback can be accessed by dialing (877) 344-7529 (U.S.) and +1-412-317-0088 (International). The passcode is 10119919.
About IsoRay, Inc.
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on Facebook/IsoRay. Follow us on Twitter @IsoRay.
Contacts: IsoRay, Inc. [email protected] (509) 375-1202 Investors: Stephanie Prince, Managing Director PCG Advisory Group [email protected] (646) 762-4518
